Novo Nordisk and Mylan Settle Ozempic, Wegovy Patent Battles – Bloomberg Law News

Mylan Pharmaceuticals Inc. and Novo Nordisk A/S settled a patent lawsuit and validity challenge linked to Novo’s blockbuster weight-loss and …